August 8, 2024 by Lori Solomon The U.S. Food and Drug Administration has approved Johnson & Johnson’s Darzalex Faspro (daratumumab and hyaluronidase-fihj) in combination with bortezomib, lenalidomide, and dexamethasone (D-VRd) for induction and consolidation in patients with newly diagnosed multiple myeloma (MM) who are eligible for an autologous stem cell transplant (ASCT). The approval was...
August 8, 2024 by Steinar Brandslet, Norwegian University of Science and Technology Credit: Pixabay/CC0 Public DomainData from nearly 6,000 smokers with cancer show that it may be easier to predict who will stop smoking than was previously thought. It is often important to get cancer patients to quit smoking, but it is not always that...
August 8, 2024 by Robin Foster Plenty of women know that having an IUD inserted in their uterus can be an excruciating experience, but new government guidance issued Thursday may soon make the experience less painful for many. For the first time, updated recommendations from the U.S. Centers for Disease Control and Prevention advise doctors...
August 7, 2024 by American Academy of Neurology Immunohistochemistry for alpha-synuclein showing positive staining (brown) of an intraneural Lewy-body in the Substantia nigra in Parkinson’s disease. Credit: WikipediaThere’s some good news for people with Parkinson’s disease: The risk of developing dementia may be lower than previously thought, or dementia may occur later in the course...
August 7, 2024 by Valerie Goodwin, University of Michigan Descriptive characteristics of adults with cerebral palsy. Credit: JAMA Neurology (2024). DOI: 10.1001/jamaneurol.2024.2443Pain management is an important component of caring for adults with cerebral palsy. However, it’s the least understood comorbidity in the adult cerebral palsy population. A study led by Mark Peterson, Ph.D., M.S., FACSM,...
News Release 7-Aug-2024 Using more comprehensive reporting strategies than in the past, researchers find significantly elevated autism risk among younger siblings Peer-Reviewed PublicationKennedy Krieger Institute image: Rebecca Landa, PhD, CCC-SLP; Vice President, Executive Director for the Center for Autism Services, Science and Innovation (CASSI) Credit: Kennedy Krieger Institute BALTIMORE, August 7, 2024— A study conducted...
August 6, 2024 by Marta Wegorzewska, Washington University School of Medicine Immunobiologists Robert Schreiber, Ph.D., (left) and Hussein Sultan, Ph.D., of Washington University School of Medicine in St. Louis, found that a subset of immune cells that normally puts the brakes on the immune system to prevent it from attacking the body’s healthy cells inadvertently...
August 7, 2024 by Dana-Farber Cancer Institute Glioma of the left parietal lobe. CT scan with contrast enhancement. Credit: Mikhail Kalinin/CC BY-SA 3.0Vorasidenib has been approved by the U.S. Food and Drug Administration (FDA) for patients with Grade 2 gliomas with IDH1 or IDH2 mutations. Based on evidence from the INDIGO clinical trial, a global...
Perspective > Medscape > Impact Factor with F. Perry WilsonCOMMENTARY F. Perry Wilson, MD, MSCE Disclosures November 20, 2023 This transcript has been edited for clarity. Welcome to Impact Factor, your weekly dose of commentary on a new medical study. I’m Dr F. Perry Wilson of the Yale School of Medicine. Robert Louis Stevenson famously...
August 6, 2024 by Johns Hopkins University School of Medicine Working with human stem cells that form a kind of “mini intestine-in-a-dish,” Johns Hopkins Medicine scientists say they have found several molecular mechanisms for COVID-19-related diarrhea, suggesting potential ways to control it. Details of the experiments in a model of human intestinal tissue, called enteroids,...
